66 related articles for article (PubMed ID: 29797935)
41. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
42. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
43. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
44. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
[TBL] [Abstract][Full Text] [Related]
45. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
46. Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line.
Xie SM; Fang WY; Liu TF; Yao KT; Zhong XY
J Oncol; 2010; 2010():915046. PubMed ID: 20628484
[TBL] [Abstract][Full Text] [Related]
47. STGC3 inhibits xenograft tumor growth of nasopharyngeal carcinoma cells by altering the expression of proteins associated with apoptosis.
Qiu QC; Hu B; He XP; Luo Q; Tang GH; Long ZF; Chen ZC; He XS
Genet Mol Biol; 2012 Jan; 35(1):18-26. PubMed ID: 22481869
[TBL] [Abstract][Full Text] [Related]
48. Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression.
Guo YH; Wang Y; Xin M
Pharm Biol; 2016 Feb; ():1-6. PubMed ID: 26916669
[TBL] [Abstract][Full Text] [Related]
49. Differential Expression and Alternative Splicing of Transcripts Associated With Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma.
Zhang J; Jiang H; Xie T; Zheng J; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y
Front Genet; 2020; 11():52. PubMed ID: 32161615
[TBL] [Abstract][Full Text] [Related]
50. Radioresistant Nasopharyngeal Carcinoma Cells Exhibited Decreased Cisplatin Sensitivity by Inducing SLC1A6 Expression.
Hao W; Wu L; Cao L; Yu J; Ning L; Wang J; Lin X; Chen Y
Front Pharmacol; 2021; 12():629264. PubMed ID: 33927617
[TBL] [Abstract][Full Text] [Related]
51. Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer.
Li S; Chen S; Dong Z; Song X; Li X; Huang Z; Li H; Huang L; Zhuang G; Lan R; Guo M; Li W; Saw PE; Zhang L
Acta Pharm Sin B; 2023 Mar; 13(3):967-981. PubMed ID: 36970197
[TBL] [Abstract][Full Text] [Related]
52. TEM observation of ultrasound-induced mitophagy in nasopharyngeal carcinoma cells in the presence of curcumin.
Wang X; Leung AW; Luo J; Xu C
Exp Ther Med; 2012 Jan; 3(1):146-148. PubMed ID: 22969860
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern].
Onco Targets Ther; 2022; 15():841-842. PubMed ID: 35958055
[No Abstract] [Full Text] [Related]
54. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
55. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
Song Y; Zhou X; Bai W; Ma X
Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-132 sensitizes nasopharyngeal carcinoma cells to cisplatin through regulation of forkhead box A1 protein.
Li YL; Zhao YG; Chen B; Li XF
Pharmazie; 2016 Dec; 71(12):715-718. PubMed ID: 29442000
[TBL] [Abstract][Full Text] [Related]
57. microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
Yuan TZ; Zhang HH; Lin XL; Yu JX; Yang QX; Liang Y; Deng J; Huang LJ; Zhang XP
Mol Med Rep; 2017 Apr; 15(4):2223-2228. PubMed ID: 28260044
[TBL] [Abstract][Full Text] [Related]
58. Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.
Xie SM; Fang WY; Liu Z; Wang SX; Li X; Liu TF; Xie WB; Yao KT
J Transl Med; 2008 Oct; 6():55. PubMed ID: 18834541
[TBL] [Abstract][Full Text] [Related]
59. [Investigation of CXCR4 mediated chemoresistance in nasopharyngeal carcinoma cell line CNE2].
Song XY; Shang XL; Zhang YT; Lin YT; Xu GG; Xue G; Zhang QJ; Zou F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(11):887-891;896. PubMed ID: 29797935
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
